Verastem, Inc. Appoints José Baselga, M.D., Ph.D., to Scientific Advisory Board
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today the appointment of José Baselga, M.D., Ph.D., to its Scientific Advisory Board.